Cytogenetics in the study of myelodysplastic syndromes
Prieto, F.; Carbonell, F.; Badía, L.; Castel, V.; Pérez Sirvent, M.L.
Sangre 30(4-C): 669-679
1985
ISSN/ISBN: 0036-4355 PMID: 4089737 Document Number: 253958
Document emailed within 1 workday
Related Documents
Vineis, P.; Avanzi, G.C.; Giovinazzo, B.; Ponzio, G.; Cambrin, G.R.; Ciccone, G. 1990: Cytogenetics and occupational exposure to solvents: a pilot study on leukemias and myelodysplastic disorders Tumori 76(4): 350-352Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481
Nisse, C.; Lorthois, C.; Dorp, V.; Eloy, E.; Haguenoer, J.M.; Fenaux, P. 1995: Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study Leukemia 9(4): 693-699
Liu, H.; He, G.-s.; Wu, D.-p.; Sun, A.-n.; Shao, Z.-h.; Qian, S.-x.; Xiao, Z.-j.; Ma, J.; Wang, S.-y.; Xu, X.-p.; Liu, T.; Jin, J.; Chen, Z.-c.; Fang, M.-y.; Chen, B.-a.; Xu, L.-p.; Shen, Z.-x.; Ruan, C.-g. 2012: Clinical efficacies and safety of HAG regimen for patients with high-risk myelodysplastic syndromes: a multicentre study Zhonghua Yi Xue Za Zhi 92(10): 689-691
Maiolo, A.T.; Cortelezzi, A.; Calori, R.; Polli, E.E. 1990: Recombinant gamma-interferon as first line therapy for high risk myelodysplastic syndromes. Italian MDS Study Group Leukemia 4(7): 480-485
Tassin, F.; Hermanne, J.P.; Schaaf-Lafontaine, N.; Herens, C.; Thiry, A.; Paulus, J.M.; Boniver, J.; Fillet, G. 1998: Myelodysplastic syndromes: preleukemic syndromes Revue Medicale de Liege 53(6): 357-362
Bernell, P.; Kimby, E.; Hast, R. 1994: Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study Leukemia 8(10): 1631-1639
Dallapiccola, B.; Mingarelli, R.; Zelante, L. 1993: Current advances in the cytogenetics and molecular biology of the diagnosis of malformation syndromes La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 15 Suppl. 1: 10-13
Dusek, J.; Bednár, B.; Dorazilová, V.; Fakan, F.; Kerekes, Z. 1990: Myelodysplastic syndromes Ceskoslovenska Patologie 26(3): 129-134
Sizoo, W.; Hagenbeek, A.; Löwenberg, B.; van 't Veer, M.B.; Sintnicolaas, K. 1987: Myelodysplastic syndromes Nederlands Tijdschrift Voor Geneeskunde 131(38): 1658-1661
Strebel, U. 1988: Myelodysplastic syndromes Therapeutische Umschau. Revue Therapeutique 45(2): 100-105
Lishner, M.; Ravid, M. 1988: Myelodysplastic syndromes Harefuah 115(3-4): 73-76
Guisasola Zulueta, M.C.; Gilsanz Fernández, C.; Tintó del Val, J.A.; García de la Fuente, A. 1986: Myelodysplastic syndromes Revista Clinica Espanola 179(4): 190-195
Tohyama, K. 2012: Treatment of myelodysplastic syndromes (MDS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 367-372
Carvajal Méndez, I.; García Vadillo, J.A.; Herranz Varela, A.; González Alvaro, I.; Casado Montero, F.; Castañeda Sanz, S. 1996: Polyarthritis associated with myelodysplastic syndromes Revista Clinica Espanola 196(8): 539-541
Solary, E.; Fontenay, M.ël. 2010: Myeloproliferative/myelodysplastic syndromes La Revue du Praticien 60(10): 1413-1415
Doll, D.C.; List, A.F. 1992: Myelodysplastic syndromes: introduction Seminars in Oncology 19(1): 1-3
Turtureanu-Hanganu, E. 2004: The point on myelodysplastic syndromes Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(1): 9-16
Hellström-Lindberg, E. 1999: Treatment of adult myelodysplastic syndromes International Journal of Hematology 70(3): 141-154
Atallah, E.; Garcia-Manero, G. 2007: Use of hypomethylating agents in myelodysplastic syndromes Clinical Advances in Hematology and Oncology: H&o 5(7): 544-552